Drastic changes to Ampligen clinical trial hurts ME patients – sign the petition to fight it

Author:

Patients in the Ampligen clinical trial are bearing the brunt of drastic changes Hemispherx has implemented that will force many to stop getting this medicine and may endanger prospects for FDA approval.
We need the community’s help in telling Hemispherx to put patients first, so we can continue to fight for FDA approval of the first medicine for ME. Sign the petition.
Four changes made by the drug maker are forcing patients off the medicine and threaten the continuation of the clinical trial:

  1. A 167% price increase.
  2. Ending the compassionate care program, which supports less than a handful of patients who need the assistance.
  3. Restricting access to current full-time enrollees only, which is prohibiting participants who take a “break” or holiday from the drug.
  4. Closing the trial to new participants.

These changes obviously affect those who are in the trial, but they also restrict future access to ME patients.
Ampligen patients have met with the company and petitioned the Board of Hemispherx saying: “Hemispherx’s changes to the program are predatory and cruel, given the desperate need for treatment among this patient population.”
Meanwhile, Hemispherx announced this week that it was shipping Ampligen inventory to Europe for use in the Early Access Program in the EU.
Ampligen patients also believe these drastic changes will harm prospects for FDA approval of this first ME medication, pointing out  to the company the central role patients have played in pushing the FDA to recognize ME and approve Ampligen:
“Patients on Ampligen have been the force behind urging the FDA to approve it. We have led dramatic efforts to change FDA’s beliefs about the disease and Ampligen’s efficacy, including 700 testimonies during the advisory committee hearing, a 5,000 plus petition to the FDA, a patient hunger strike protesting FDA denial, a stakeholder and other important meetings at FDA, and Congressional and HHS outreach.”
The entire ME community has an interest in the successful pursuit of FDA approval for the first medicine for our disease. Approval of the first ME medication will lead to more clinical trials and investment by the larger pharmaceutical industry. Reducing the Ampligen trial is not a successful strategy for FDA approval.
Please join Ampligen patients in making sure Hemispherx puts ME patients first to prevent damage to participants’ health and future approval prospects.
Sign the petition to tell Hemispherx to reverse these draconian changes to the Ampligen clinical trial that will hurt the ME community.
 

Facebook
Twitter
WhatsApp
Email

2 thoughts on “Drastic changes to Ampligen clinical trial hurts ME patients – sign the petition to fight it”

  1. This type of issue requires civil disobedience targeting the pharma company. I would be surprised if pharma did anything after receiving a petition.

  2. I seriously do not understand this article.
    To the best of my knowledge, there is no current trial of Ampligen in the US. So how can there be any changes to it, if it doesn’t exist?

Comments are closed.

Latest News

#MEAction logo is in white in the top left corner and the words Colorado State Chapter are in white laying across an image of snow capped mountains and pine trees. There is a bottom section of the image that is a green box with the words Working-With-Governors-Office-to-Create A New Senior Policy Advisor Role-Leading to Statewide Report on Long COVID

#MEAction Colorado Works With Governor’s Office to Create A New Senior Policy Advisor Role on Long COVID and Post Viral Infection Planning–Leading to Statewide Report on Long COVID

#MEAction Colorado’s first legislative effort in Colorado began with an ME/CFS day declaration in the Colorado Legislature on February 25, 2020. Representative Alex Valdez read into the legislative record a proclamation about the presence of and deleterious effects of ME in Colorado. This effort was relatively easy to accomplish and consisted of finding a representative

Read More »
Left: Woman healthy and happy standing beside her husband. Right: Sick woman in hospital bed.

Woman with Severe ME and EDS starving to death in NHS hospital

UPDATE: We want to provide a brief update on Sami Berry’s case and what she needs help with now. The situation in hospital reached the point that Sami decided she had to self-discharge to try and stay alive. She is at home with a Percutaneous Endoscopic Jejunostomy (PEJ ) tube but she needs treatment with

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top